|
PRDM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.903810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.376000E-01 |
| Normal-vs-Stage2 |
1.020420E-01 |
| Normal-vs-Stage3 |
4.282000E-01 |
| Normal-vs-Stage4 |
5.725600E-01 |
| Stage1-vs-Stage2 |
1.760450E-01 |
| Stage1-vs-Stage3 |
8.123800E-01 |
| Stage1-vs-Stage4 |
3.347400E-01 |
| Stage2-vs-Stage3 |
3.025200E-01 |
| Stage2-vs-Stage4 |
8.196000E-02 |
| Stage3-vs-Stage4 |
4.127000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.391200E-01 |
| Normal-vs-AfricanAmerican |
1.150380E-01 |
| Normal-vs-Asian |
6.512400E-01 |
| Caucasian-vs-AfricanAmerican |
1.883220E-01 |
| Caucasian-vs-Asian |
8.024600E-01 |
| AfricanAmerican-vs-Asian |
8.353400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.871400E-01 |
| Normal-vs-Female |
1.149020E-01 |
| Male-vs-Female |
2.994800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.975650E-01 |
| Normal-vs-Extreme_Weight |
8.468200E-01 |
| Normal-vs-Obese |
2.269600E-01 |
| Normal-vs-Extreme_Obese |
1.925900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.497400E-01 |
| Normal_Weight-vs-Obese |
8.690200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.561200E-03 |
| Extreme_Weight-vs-Obese |
2.922200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.336010E-02 |
| Obese-vs-Extreme_Obese |
6.224700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.126100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.591200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.464600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.299000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.920200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.267580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.934200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.827800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.857000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.499000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.929400E-01 |
| Normal-VS-Type2 PRCC |
1.162020E-01 |
| Normal-VS-KIRP CIMP |
7.139600E-02 |
| Normal-VS-Unclassified PRCC |
9.994400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.340200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.685800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.034080E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.514400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.758400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.088200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.564800E-01 |
| Normal-vs-N1 |
3.059400E-01 |
| Normal-vs-N2 |
9.456000E-01 |
| N0-vs-N1 |
6.003800E-01 |
| N0-vs-N2 |
8.748600E-01 |
| N1-vs-N2 |
6.807800E-01 |
|
|
